267,508 Shares in NKGen Biotech, Inc. (NYSE:NKGN) Bought by Magnetar Financial LLC

Magnetar Financial LLC acquired a new stake in NKGen Biotech, Inc. (NYSE:NKGN) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 267,508 shares of the company’s stock, valued at approximately $175,000. Magnetar Financial LLC owned approximately 0.60% of NKGen Biotech at the end of the most recent reporting period.

Separately, Sequoia Financial Advisors LLC boosted its position in shares of NKGen Biotech by 126.1% in the 4th quarter. Sequoia Financial Advisors LLC now owns 156,000 shares of the company’s stock valued at $102,000 after purchasing an additional 87,000 shares during the period. Institutional investors and hedge funds own 76.17% of the company’s stock.

NKGen Biotech Stock Down 3.0 %

NKGN opened at $0.16 on Monday. NKGen Biotech, Inc. has a 52 week low of $0.10 and a 52 week high of $2.57. The business’s 50 day moving average is $0.42 and its two-hundred day moving average is $0.45. The firm has a market cap of $6.98 million, a price-to-earnings ratio of -0.03 and a beta of 0.45.

About NKGen Biotech

NKGen Biotech, Inc operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials.